Bioincubator Lab In Natick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Home / Top News / Cytovia Therapeutics Opens Boston R&D Center of Excellence and Announces cGMP Manufacturing Facility, Aiming to Start Clinical Trials for its Gene-Edited iPSC CAR-NK Cells by 2022
Cytovia Therapeutics Opens Boston R&D Center of Excellence and Announces cGMP Manufacturing Facility, Aiming to Start Clinical Trials for its Gene-Edited iPSC CAR-NK Cells by 2022
R&D labs for NK cell biology, gene-editing, antibody and CAR development, and NK cell pilot manufacturing opens in Natick, MA
Cell therapy manufacturing facility with best-in-industry clinical and commercial capacity to open in Aguadilla, Puerto Rico
CAMBRIDGE, Mass. and AVENTURA, Fla., March 17, 2021 (GLOBE NEWSWIRE) Cytovia Therapeutics, Inc., a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited Chimeric Antigen Receptor (CAR)-NK cells derived from induced pluripotent stem cells (iPSCs) and NK-Engager Bispecific antibodies, announced today two agreements for R&D ....

New York , United States , Puerto Rico , Israel General , United Kingdom , Chris Maggos , Anna Baran Djokovic , Raphael Nir , Robert Salcedo , Daniel Chang , York Stem Cell Foundation , Innovation Lab , Bioincubator Lab In Natick , Cytovia Therapeutics Inc , Hebrew University Of Jerusalem , University Of California San Francisco , Cytovia Therapeutics , Chimeric Antigen Receptor , Engager Bispecific , New York Stem Cell Foundation , Chief Scientific Officer , Managing Partner , Natural Killer , Hebrew University , California San Francisco , Social Media ,